Literature DB >> 11927966

Testicular seminoma: a clinicopathologic and immunohistochemical study of 105 cases with special reference to seminomas with atypical features.

Satish K Tickoo1, Brian Hutchinson, Jennifer Bacik, Madhu Mazumdar, Robert J Motzer, Dean F Bajorin, George J Bosl, Victor E Reuter.   

Abstract

In spite of the high curability rates, rare cases of testicular seminoma behave in an unexpectedly aggressive manner. No effective markers are currently available that can predict such uncommon behavior. We studied 105 cases of testicular seminoma on whom the primary resection was performed at the Memorial Sloan-Kettering Cancer Center, New York, to investigate any relationship between morphology, immunohistochemical features, and clinical/pathological stages. Fifty-nine percent of the cases presented with pT stage 1 and 74 percent with American Joint Committee on Cancer (AJCC) stage I. In univariate analysis, tumor size, mitotic count, and presence of necrosis showed significant associations with pT stage (p = 0.0001, 0.0001, and 0.04, respectively), and the presence of vascular invasion (p = 0.0001, 0.0001, and 0.02, respectively). In multivariate analysis, both the tumor size and mitotic counts were independent predictors of pT stage (p = 0.0004 and 0.0001) and vascular invasion (p = 0.0004 and 0.0001). When tumors were separated on the basis of architectural and/or cytological atypia into "usual seminomas" and "seminomas with atypia", these were significantly associated with AJCC stage (p = 0.02), and c-kit protein (p = 0.0005) and CD30 expression (p = 0.02). In addition, "seminomas with atypia" also tended to show a higher proliferation activity as judged by Ki67 reactivity (p = 0.06), as well as express the marker of epithelial differentiation, Cam 5.2 (p = 0.09). In summary, we find that the morphologic features in testicular seminomas are associated with factors of clinical relevance. Also, "seminomas with atypia" differ from "usual seminomas" morphologically, present at a higher AJCC stage, and possibly represent an early step in transformation of seminomas toward a more aggressive phenotype. While not proposing a new entity, we suggest that when these atypical features are encountered in an otherwise classical seminoma, investigations must be performed to exclude an early carcinomatous differentiation or even earlier changes toward such a differentiation, such as lack of c-kit protein expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11927966     DOI: 10.1177/106689690201000105

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  15 in total

1.  ZBTB16: a novel sensitive and specific biomarker for yolk sac tumor.

Authors:  Guang-Qian Xiao; Faqian Li; Pamela D Unger; Hani Katerji; Qi Yang; Loralee McMahon; David E Burstein
Journal:  Mod Pathol       Date:  2016-02-26       Impact factor: 7.842

2.  Recent developments in the management of germ cell tumors.

Authors:  Pavlos Msaouel; Mehmet A Bilen; Miao Zhang; Matthew Campbell; Jennifer Wang; Shi-Ming Tu
Journal:  Curr Opin Oncol       Date:  2017-05       Impact factor: 3.645

3.  Sonographically documented stable seminoma: a case report.

Authors:  Nathan Moore; Timo Laurila; David F Jarrard
Journal:  Int Urol Nephrol       Date:  2007-02-28       Impact factor: 2.370

4.  Handling and reporting of orchidectomy specimens with testicular cancer: areas of consensus and variation among 25 experts and 225 European pathologists.

Authors:  Daniel M Berney; Ferran Algaba; Mahul Amin; Brett Delahunt; Eva Compérat; Jonathan I Epstein; Peter Humphrey; Mohammed Idrees; Antonio Lopez-Beltran; Cristina Magi-Galluzzi; Gregor Mikuz; Rodolfo Montironi; Esther Oliva; John Srigley; Victor E Reuter; Kiril Trpkov; Thomas M Ulbright; Murali Varma; Clare Verrill; Robert H Young; Ming Zhou; Lars Egevad
Journal:  Histopathology       Date:  2015-03-17       Impact factor: 5.087

5.  SALL4 is a useful marker in the diagnostic work-up of germ cell tumors in extra-testicular locations.

Authors:  Philippe Camparo; Eva Maria Comperat
Journal:  Virchows Arch       Date:  2012-12-09       Impact factor: 4.064

6.  Mixed germ cell sex cord-stromal tumors of the testis and ovary. Morphological, immunohistochemical, and molecular genetic study of seven cases.

Authors:  Michal Michal; Tomas Vanecek; Radek Sima; Petr Mukensnabl; Ondrej Hes; Dmitry V Kazakov; Jozef Matoska; Anna Zuntova; Vladimir Dvorak; Alexander Talerman
Journal:  Virchows Arch       Date:  2006-03-15       Impact factor: 4.064

Review 7.  [Testicular seminomas. The classical and the less classical ones].

Authors:  P K Bode; H Moch
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

Review 8.  Emerging Therapeutic Targets for Male Germ Cell Tumors.

Authors:  Christian Daniel Fankhauser; Friedemann Honecker; Jörg Beyer; Peter Karl Bode
Journal:  Curr Oncol Rep       Date:  2015-12       Impact factor: 5.075

9.  KIT mutations are common in testicular seminomas.

Authors:  Kathleen Kemmer; Christopher L Corless; Jonathan A Fletcher; Laura McGreevey; Andrea Haley; Diana Griffith; Oscar W Cummings; Cecily Wait; Ajia Town; Michael C Heinrich
Journal:  Am J Pathol       Date:  2004-01       Impact factor: 4.307

10.  Supraclavicular left neck mass: an unusual presentation of metastatic testicular cancer in two older men.

Authors:  Chinnoi Law; Zainab AlshiekhAli; Nicholas Taylor; David Howlett
Journal:  BMJ Case Rep       Date:  2020-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.